Literature DB >> 8633003

Serotonergic modulation of muscle acetylcholine receptors of different subunit composition.

J García-Colunga1, R Miledi.   

Abstract

Modulation of muscle acetylcholine (AcCho) receptors (AcChoRs) by serotonin [5-hydroxytryptamine (5HT)] and other serotonergic compounds was studied in Xenopus laevis oocytes. Various combinations of alpha, beta, gamma, and delta subunit RNAs were injected into oocytes, and membrane currents elicited by AcCho were recorded under voltage clamp. Judging by the amplitudes of AcCho currents generated, the levels of functional receptor expression were: alpha beta gamma delta > alpha beta delta > alpha beta gamma > alpha gamma delta. The alpha beta gamma delta and alpha beta delta AcChoR Subtypes were strongly blocked by 5HT, whereas the alpha beta gamma receptor was blocked only slightly. The order of blocking potency of AcChoRs by 5HT was: alpha beta delta > alpha beta gamma delta > alpha beta gamma. 5HT receptor antagonists, such as methysergide and spiperone, were even more potent blockers of AcChoRs than 5HT but did not show much subunit selectivity. Blockage of alpha beta gamma delta and alpha beta delta receptors by 5HT was voltage-dependent, and the voltage dependence was abolished when the delta subunit was omitted. These findings may need to be taken into consideration when trying to elucidate the mode of action of many clinically important serotonergic compounds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633003      PMCID: PMC39473          DOI: 10.1073/pnas.93.9.3990

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Structural invariants in protein folding.

Authors:  C Chothia
Journal:  Nature       Date:  1975-03-27       Impact factor: 49.962

2.  Role of acetylcholine receptor subunits in gating of the channel.

Authors:  B Sakmann; C Methfessel; M Mishina; T Takahashi; T Takai; M Kurasaki; K Fukuda; S Numa
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

3.  The ion channel of the nicotinic acetylcholine receptor is formed by the homologous helices M II of the receptor subunits.

Authors:  F Hucho; W Oberthür; F Lottspeich
Journal:  FEBS Lett       Date:  1986-09-01       Impact factor: 4.124

4.  Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine.

Authors:  J Giraudat; M Dennis; T Heidmann; J Y Chang; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  An action of 5-hydroxytryptamine on the frog motor end-plate.

Authors:  F Colomo; R Rahamimoff; E Stefani
Journal:  Eur J Pharmacol       Date:  1968-06       Impact factor: 4.432

6.  A structural model of the acetylcholine receptor channel based on partition energy and helix packing calculations.

Authors:  H R Guy
Journal:  Biophys J       Date:  1984-01       Impact factor: 4.033

7.  Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor.

Authors:  J Finer-Moore; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity.

Authors:  S M Sine; K Ohno; C Bouzat; A Auerbach; M Milone; J N Pruitt; A G Engel
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

9.  Cholinergic and catecholaminergic receptors in the Xenopus oocyte membrane.

Authors:  K Kusano; R Miledi; J Stinnakre
Journal:  J Physiol       Date:  1982-07       Impact factor: 5.182

10.  Ionic blockage of sodium channels in nerve.

Authors:  A M Woodhull
Journal:  J Gen Physiol       Date:  1973-06       Impact factor: 4.086

View more
  9 in total

1.  Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.

Authors:  E Palma; L Maggi; F Eusebi; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Modulation of nicotinic acetylcholine receptors by strychnine.

Authors:  J García-Colunga; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).

Authors:  J García-Colunga; J N Awad; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  Activation of volume-regulated Cl(-) channels by ACh and ATP in Xenopus follicles.

Authors:  A L Pérez-Samartín; R Miledi; R O Arellano
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

5.  The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.

Authors:  Silvia Olivera-Bravo; Isabel Ivorra; Andrés Morales
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

6.  Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.

Authors:  E Palma; A M Mileo; F Eusebi; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Dopamine and serotonin modulate human GABAρ1 receptors expressed in Xenopus laevis oocytes.

Authors:  Lenin D Ochoa-de la Paz; Argel Estrada-Mondragón; Agenor Limón; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  ACS Chem Neurosci       Date:  2011-12-09       Impact factor: 4.418

Review 8.  Marine sponges as pharmacy.

Authors:  Detmer Sipkema; Maurice C R Franssen; Ronald Osinga; Johannes Tramper; René H Wijffels
Journal:  Mar Biotechnol (NY)       Date:  2005-03-24       Impact factor: 3.619

9.  Methylpiperidinium Iodides as Novel Antagonists for α7 Nicotinic Acetylcholine Receptors.

Authors:  Jhon J López; Jesús García-Colunga; Edwin G Pérez; Angélica Fierro
Journal:  Front Pharmacol       Date:  2018-07-10       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.